A novel biomarker GATM suppresses proliferation and malignancy of cholangiocarcinoma cells by modulating the JNK/c-Jun signalling pathways
Author:
Yu Yi,
Gan Wei,
Xiong Jianping,
Li JunheORCID
Reference52 articles.
1. Expert consensus document: cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA);Banales;Nat. Rev. Gastroenterol. Hepatol.,2016
2. Cholangiocarcinoma - evolving concepts and therapeutic strategies;Rizvi;Nat. Rev. Clin. Oncol.,2018
3. Biliary tract cancer;Valle;Lancet,2021
4. Intrahepatic cholangiocarcinoma: epidemiology, risk factors, diagnosis and surgical management;Zhang;Cancer Lett.,2016
5. Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study;Primrose;Lancet Oncol.,2019